Cervical dysplasia: Difference between revisions
Jump to navigation
Jump to search
m CC-BY 2.0 inline |
m →p16 immunostaining: thumb |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Top | <noinclude>{{Top | ||
|author1=[[User:Mikael Häggström|Mikael Häggström]] | |author1=[[User:Mikael Häggström|Mikael Häggström]] | ||
|author2= | |author2= | ||
| Line 8: | Line 8: | ||
*'''[[Cervical cone]]''' | *'''[[Cervical cone]]''' | ||
*'''[[Hysterectomy]]''' | *'''[[Hysterectomy]]''' | ||
</noinclude> | |||
==Microscopic evaluation== | ==Microscopic evaluation== | ||
'''Dysplasia''' is mainly seen as nuclei with hyperchromasia, coarse chromatin and irregular contours.<ref>{{cite web|url=https://www.pathologyoutlines.com/topic/cervixHSILCINIII.html|title=HSIL / CIN II / CIN III|website=PathologyOutlines|author=Khaled J. Alkhateeb, M.B.B.S., Ziyan T. Salih, M.D.}} Topic Completed: 29 March 2021. Minor changes: 9 February 2022</ref> | '''Dysplasia''' is mainly seen as nuclei with hyperchromasia, coarse chromatin and irregular contours.<ref>{{cite web|url=https://www.pathologyoutlines.com/topic/cervixHSILCINIII.html|title=HSIL / CIN II / CIN III|website=PathologyOutlines|author=Khaled J. Alkhateeb, M.B.B.S., Ziyan T. Salih, M.D.}} Topic Completed: 29 March 2021. Minor changes: 9 February 2022</ref> | ||
| Line 47: | Line 47: | ||
* May also be referred to as cervical carcinoma in situ | * May also be referred to as cervical carcinoma in situ | ||
| [[File:Histopathology of CIN 3.jpg|200px]] | | [[File:Histopathology of CIN 3.jpg|200px]] | ||
|- | |||
| '''[[Invasive squamous cell carcinoma of the cervix|Invasive squamous-<br>cell carcinoma<br>of the cervix]]''' | |||
| | |||
| Infiltration as irregular anastomosing nests or single cells.<ref>{{cite web|url=https://www.pathologyoutlines.com/topic/cervixscc.html|title=Cervix - Squamous cell carcinoma and variants|website=Pathology Outlines|author=Author: Gulisa Turashvili, M.D., Ph.D.}} Last author update: 24 September 2020. Last staff update: 13 December 2022</ref> | |||
| [[File:Histopathology of squamous cell carcinoma of the cervix.png|200px]] | |||
|} | |} | ||
<gallery mode=packed heights=190px> | <gallery mode=packed heights=190px> | ||
File:Spectrum of SIL cervical dysplasia.png|Spectrum from normal to high grade SIL.<ref group= | File:Spectrum of SIL cervical dysplasia.png|Spectrum from normal to high grade SIL.<ref group=image>Ed Uthman from Houston, TX, USA. {{CC-BY 2.0 inline}}</ref> | ||
File:Histopathology of CIN 3 with endocervical gland invasion.jpg|'''Endocervical gland invasion''' is associated with high-grade lesions.<ref name="NagiSchlosshauer2006">{{cite journal|last1=Nagi|first1=Chandandeep S.|last2=Schlosshauer|first2=Peter W.|title=Endocervical glandular involvement is associated with high-grade SIL|journal=Gynecologic Oncology|volume=102|issue=2|year=2006|pages=240–243|issn=00908258|doi=10.1016/j.ygyno.2005.12.029}}</ref> | File:Histopathology of CIN 3 with endocervical gland invasion.jpg|'''Endocervical gland invasion''' is associated with high-grade lesions.<ref name="NagiSchlosshauer2006">{{cite journal|last1=Nagi|first1=Chandandeep S.|last2=Schlosshauer|first2=Peter W.|title=Endocervical glandular involvement is associated with high-grade SIL|journal=Gynecologic Oncology|volume=102|issue=2|year=2006|pages=240–243|issn=00908258|doi=10.1016/j.ygyno.2005.12.029}}</ref> | ||
File:Invasive Squamous Carcinoma of the Cervix. Cold Knife Cone (6076190079).jpg|'''Invasive cervical cancer''' is most commonly squamous cell carcinoma (about 80–85%<ref>{{cite web|title=What Is Cervical Cancer?|url=https://www.cancer.org/cancer/cervical-cancer/about/what-is-cervical-cancer.html|publisher=American Cancer Society}}</ref><ref>{{cite web|title=Cervical cancer – Types and grades|url=http://www.cancerresearchuk.org/about-cancer/cervical-cancer/stages-types-grades/types-and-grades|publisher=Cancer Research UK}}</ref> of cervical cancers). In contrast to tangentially cut projections of glands involved by HSIL, the invasive nests of tumor cells are irregular and accompanied by a distinct stromal reaction of edema and chronic inflammatory cells.<ref group= | File:Invasive Squamous Carcinoma of the Cervix. Cold Knife Cone (6076190079).jpg|'''Invasive cervical cancer''' is most commonly squamous cell carcinoma (about 80–85%<ref>{{cite web|title=What Is Cervical Cancer?|url=https://www.cancer.org/cancer/cervical-cancer/about/what-is-cervical-cancer.html|publisher=American Cancer Society}}</ref><ref>{{cite web|title=Cervical cancer – Types and grades|url=http://www.cancerresearchuk.org/about-cancer/cervical-cancer/stages-types-grades/types-and-grades|publisher=Cancer Research UK}}</ref> of cervical cancers). In contrast to tangentially cut projections of glands involved by HSIL, the invasive nests of tumor cells are irregular and accompanied by a distinct stromal reaction of edema and chronic inflammatory cells.<ref group=image>[https://commons.wikimedia.org/wiki/File:Invasive_Squamous_Carcinoma_of_the_Cervix._Cold_Knife_Cone_(6076190079).jpg Invasive Squamous Carcinoma of the Cervix. Cold Knife Cone (6076190079).jpg] by Ed Uthman, MD. {{CC-BY 2.0 inline}}</ref> | ||
</gallery> | </gallery> | ||
| Line 67: | Line 72: | ||
===p16 immunostaining=== | ===p16 immunostaining=== | ||
[[File:CIN 2 (HSIL), p16 Immunostain (7205728160).jpg|thumb|'''p16''' staining. To support a diagnosis of high-grade SIL, the reaction needs to be strong and diffuse, as seen here.]] | [[File:CIN 2 (HSIL), p16 Immunostain (7205728160).jpg|thumb|'''p16''' staining. To support a diagnosis of high-grade SIL, the reaction needs to be strong and diffuse, as seen here.]] | ||
[[File:Invasive cervical squamous cell carcinoma on H&E histopathology and Ki-67 immunohistochemistry.jpg|thumb|Invasive cervical squamous cell carcinoma on H&E histopathology and Ki-67 immunohistochemistry. The latter correlates well with the degree and level of dysplasia.<ref>Image by Mikael Häggström, MD. Source for caption: {{cite journal| author=Ghosh A, M N, Padmanabha N, Kini H| title=Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation. | journal=Iran J Pathol | year= 2020 | volume= 15 | issue= 4 | pages= 268-273 | pmid=32944038 | doi=10.30699/ijp.2020.112421.2208 | pmc=7477676 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32944038 }} </ref>]] | |||
Indications for p16 immunostaining are:<ref name="pmid26572990">{{cite journal| author=Clinton LK, Miyazaki K, Ayabe A, Davis J, Tauchi-Nishi P, Shimizu D| title=The LAST guidelines in clinical practice: implementing recommendations for p16 use. | journal=Am J Clin Pathol | year= 2015 | volume= 144 | issue= 6 | pages= 844-9 | pmid=26572990 | doi=10.1309/AJCPUXLP7XD8OQYY | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26572990 }}</ref> | Indications for p16 immunostaining are:<ref name="pmid26572990">{{cite journal| author=Clinton LK, Miyazaki K, Ayabe A, Davis J, Tauchi-Nishi P, Shimizu D| title=The LAST guidelines in clinical practice: implementing recommendations for p16 use. | journal=Am J Clin Pathol | year= 2015 | volume= 144 | issue= 6 | pages= 844-9 | pmid=26572990 | doi=10.1309/AJCPUXLP7XD8OQYY | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26572990 }}</ref> | ||
*To differentiate between HSIL and mimics such as atrophy, immature squamous metaplasia, or tangential cuts. | *To differentiate between HSIL and mimics such as atrophy, immature squamous metaplasia, or tangential cuts. | ||
| Line 85: | Line 91: | ||
The transition zone has thickened endocervical epithelium with poorly differentiated neoplastic cells, which span more than half of the epithelial thickness, and with invasion of endocervical glands. Otherwise, glands are clad by a simple columnar epithelium without atypia. The neoplastic cells are radically removed. | The transition zone has thickened endocervical epithelium with poorly differentiated neoplastic cells, which span more than half of the epithelial thickness, and with invasion of endocervical glands. Otherwise, glands are clad by a simple columnar epithelium without atypia. The neoplastic cells are radically removed. | ||
|} | |} | ||
{{Bottom}} | <noinclude>{{Bottom}}</noinclude> | ||
Latest revision as of 14:03, 10 December 2023
Author:
Mikael Häggström [note 1]
Presentations
Cervical dysplasia specimens may present as:
Microscopic evaluation
Dysplasia is mainly seen as nuclei with hyperchromasia, coarse chromatin and irregular contours.[1]
Dysplasia grading
| Histology Grade | Corresponding Cytology | Description | Image |
|---|---|---|---|
| CIN 1 (Grade I) | Low-grade squamous intraepithelial lesion (LSIL) |
|
|
| CIN 2/3 | High-grade squamous intraepithelial lesion (HSIL)[notes 1] |
|
|
| CIN 2 (Grade II)[notes 2] |
|
||
| CIN 3 (Grade III)[notes 3] |
|
||
| Invasive squamous- cell carcinoma of the cervix |
Infiltration as irregular anastomosing nests or single cells.[2] |
-
Spectrum from normal to high grade SIL.[image 1]
-
Endocervical gland invasion is associated with high-grade lesions.[3]
-
Invasive cervical cancer is most commonly squamous cell carcinoma (about 80–85%[4][5] of cervical cancers). In contrast to tangentially cut projections of glands involved by HSIL, the invasive nests of tumor cells are irregular and accompanied by a distinct stromal reaction of edema and chronic inflammatory cells.[image 2]
Radicality

Look whether there is normal epithelium on each side of all slices where neoplasia is seen, and when the epithelium is missing in any direction, consider ordering additional serial sections or step sections.
HPV changes
Also look koilocytic changes of human papillomavirus (HPV), with such cells typically displaying:
- Nuclear enlargement (two to three times normal size).
- Irregularity of the nuclear membrane contour, creating a wrinkled or raisinoid appearance.
- A darker than normal staining pattern in the nucleus, known as hyperchromasia.
- Perinuclear cytoplasmic vacuolization ("nuclear halo").
p16 immunostaining


Indications for p16 immunostaining are:[7]
- To differentiate between HSIL and mimics such as atrophy, immature squamous metaplasia, or tangential cuts.
- If a diagnosis of cervical intraepithelial neoplasia grade 2 (CIN2) is considered
- In case of professional disagreement.
- Cases of high-risk colposcopic referral situations where the H&E biopsy specimen is interpreted as LSIL or lower.
Microscopy report
If a neoplasia is found, the report should include:[8]
- The histolopathological type and degree of differentiation
- Location and extent, if possible (generally not on biopsies)
- Radicality, if possible (generally not in biopsies)
Notes
- ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.
Main page
References
- ↑ Khaled J. Alkhateeb, M.B.B.S., Ziyan T. Salih, M.D.. HSIL / CIN II / CIN III. PathologyOutlines. Topic Completed: 29 March 2021. Minor changes: 9 February 2022
- ↑ Author: Gulisa Turashvili, M.D., Ph.D.. Cervix - Squamous cell carcinoma and variants. Pathology Outlines. Last author update: 24 September 2020. Last staff update: 13 December 2022
- ↑ Nagi, Chandandeep S.; Schlosshauer, Peter W. (2006). "Endocervical glandular involvement is associated with high-grade SIL ". Gynecologic Oncology 102 (2): 240–243. doi:. ISSN 00908258.
- ↑ . What Is Cervical Cancer?. American Cancer Society.
- ↑ . Cervical cancer – Types and grades. Cancer Research UK.
- ↑ Image by Mikael Häggström, MD. Source for caption: Ghosh A, M N, Padmanabha N, Kini H (2020). "Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation. ". Iran J Pathol 15 (4): 268-273. doi:. PMID 32944038. PMC: 7477676. Archived from the original. .
- ↑ Clinton LK, Miyazaki K, Ayabe A, Davis J, Tauchi-Nishi P, Shimizu D (2015). "The LAST guidelines in clinical practice: implementing recommendations for p16 use. ". Am J Clin Pathol 144 (6): 844-9. doi:. PMID 26572990. Archived from the original. .
- ↑ Monica Dahlgren, Janne Malina, Anna Måsbäck, Otto Ljungberg. Stora utskärningen. KVAST (Swedish Society of Pathology). Retrieved on 2019-09-26.
Image sources
- ↑ Ed Uthman from Houston, TX, USA. Creative Commons Attribution 2.0 Generic (CC BY 2.0) license
- ↑ Invasive Squamous Carcinoma of the Cervix. Cold Knife Cone (6076190079).jpg by Ed Uthman, MD. Creative Commons Attribution 2.0 Generic (CC BY 2.0) license
